Potential Suicide Prophylactic Activity by the Fish Oil Metabolite, 4-Hydroxyhexenal
Abstract
:1. Introduction
2. Prevention of Suicide by NRF2 Activation
3. NRF2 Activation in Response to DHA
4. Discussion
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Huan, M.; Hamazaki, K.; Sun, Y.; Itomura, M.; Liu, H.; Kang, W.; Watanabe, S.; Terasawa, K.; Hamazaki, T. Suicide attempt and n-3 fatty acid levels in red blood cells: A case control study in China. Biol. Psychiatry 2004, 56, 490–496. [Google Scholar] [CrossRef] [PubMed]
- Lewis, M.D.; Hibbeln, J.R.; Johnson, J.E.; Lin, Y.H.; Hyun, D.Y.; Loewke, J.D. Suicide deaths of active-duty US military and omega-3 fatty-acid status: A case-control comparison. J. Clin. Psychiatry 2011, 72, 1585–1590. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sublette, M.E.; Hibbeln, J.R.; Galfalvy, H.; Oquendo, M.A.; Mann, J.J. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am. J. Psychiatry 2006, 163, 1100–1102. [Google Scholar] [CrossRef] [PubMed]
- McNamara, R.K.; Jandacek, R.; Tso, P.; Dwivedi, Y.; Ren, X.; Pandey, G.N. Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease. J. Psychiatr. Res. 2013, 47, 1187–1191. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vaz, J.S.; Kac, G.; Nardi, A.E.; Hibbeln, J.R. Omega-6 fatty acids and greater likelihood of suicide risk and major depression in early pregnancy. J. Affect. Disord. 2014, 152–154, 76–82. [Google Scholar] [CrossRef] [Green Version]
- Browning, L.M.; Walker, C.G.; Mander, A.P.; West, A.L.; Madden, J.; Gambell, J.M.; Young, S.; Wang, L.; Jebb, S.A.; Calder, P.C. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am. J. Clin. Nutr. 2012, 96, 748–758. [Google Scholar] [CrossRef] [Green Version]
- Calder, P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013, 75, 645–662. [Google Scholar] [CrossRef] [Green Version]
- Martins, J.G. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: Evidence from a meta-analysis of randomized controlled trials. J. Am. Coll. Nutr. 2009, 28, 525–542. [Google Scholar] [CrossRef]
- Sublette, M.E.; Ellis, S.P.; Geant, A.L.; Mann, J.J. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J. Clin. Psychiatry 2011, 72, 1577–1584. [Google Scholar] [CrossRef] [Green Version]
- Kalkman, H.O.; Hersberger, M.; Walitza, S.; Berger, G.E. Disentangling the Molecular Mechanisms of the Antidepressant Activity of Omega-3 Polyunsaturated Fatty Acid: A Comprehensive Review of the Literature. Int. J. Mol. Sci. 2021, 22, 4393. [Google Scholar] [CrossRef]
- Meltzer, H.Y.; Alphs, L.; Green, A.I.; Altamura, A.C.; Anand, R.; Bertoldi, A.; Bourgeois, M.; Chouinard, G.; Islam, M.Z.; Kane, J.; et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch. Gen. Psychiatry 2003, 60, 82–91. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cipriani, A.; Pretty, H.; Hawton, K.; Geddes, J.R. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials. Am. J. Psychiatry 2005, 162, 1805–1819. [Google Scholar] [CrossRef] [PubMed]
- Price, R.B.; Nock, M.K.; Charney, D.S.; Mathew, S.J. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol. Psychiatry 2009, 66, 522–526. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Price, R.B.; Iosifescu, D.V.; Murrough, J.W.; Chang, L.C.; Al Jurdi, R.K.; Iqbal, S.Z.; Soleimani, L.; Charney, D.S.; Foulkes, A.L.; Mathew, S.J. Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment-resistant depression. Depress. Anxiety 2014, 31, 335–343. [Google Scholar] [CrossRef] [PubMed]
- Kalkman, H.O. The GSK3-NRF2 axis in suicide. Psychiatry Int. 2021, 2, 108–119. [Google Scholar] [CrossRef]
- Cuadrado, A.; Manda, G.; Hassan, A.; Alcaraz, M.J.; Barbas, C.; Daiber, A.; Ghezzi, P.; León, R.; López, M.G.; Oliva, B.; et al. Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach. Pharmacol. Rev. 2018, 70, 348–383. [Google Scholar] [CrossRef] [Green Version]
- Bellezza, I.; Giambanco, I.; Minelli, A.; Donato, R. Nrf2-Keap1 signaling in oxidative and reductive stress. Biochim. Biophys. Acta Mol. Cell Res. 2018, 1865, 721–733. [Google Scholar] [CrossRef]
- Cuadrado, A.; Rojo, A.I.; Wells, G.; Hayes, J.D.; Cousin, S.P.; Rumsey, W.L.; Attucks, O.C.; Franklin, S.; Levonen, A.L.; Kensler, T.W.; et al. Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. Nat. Rev. Drug Discov. 2019, 18, 295–317. [Google Scholar] [CrossRef] [Green Version]
- Cipollina, C. Endogenous Generation and Signaling Actions of Omega-3 Fatty Acid Electrophilic Derivatives. Biomed Res. Int. 2015, 2015, 501792. [Google Scholar] [CrossRef] [Green Version]
- Jamil, M.U.; Kim, J.; Yum, H.W.; Kim, S.H.; Kim, S.J.; Kim, D.H.; Cho, N.C.; Na, H.K.; Surh, Y.J. 17-Oxo-docosahexaenoic acid induces Nrf2-mediated expression of heme oxygenase-1 in mouse skin in vivo and in cultured murine epidermal cells. Arch. Biochem. Biophys. 2020, 679, 108156. [Google Scholar] [CrossRef]
- Gao, L.; Wang, J.; Sekhar, K.R.; Yin, H.; Yared, N.F.; Schneider, S.N.; Sasi, S.; Dalton, T.P.; Anderson, M.E.; Chan, J.Y.; et al. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J. Biol. Chem. 2007, 282, 2529–2537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ishikado, A.; Morino, K.; Nishio, Y.; Nakagawa, F.; Mukose, A.; Sono, Y.; Yoshioka, N.; Kondo, K.; Sekine, O.; Yoshizaki, T.; et al. 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation. PLoS ONE 2013, 8, e69415. [Google Scholar] [CrossRef] [PubMed]
- Ishikado, A.; Nishio, Y.; Morino, K.; Ugi, S.; Kondo, H.; Makino, T.; Kashiwagi, A.; Maegawa, H. Low concentration of 4-hydroxy hexenal increases heme oxygenase-1 expression through activation of Nrf2 and antioxidative activity in vascular endothelial cells. Biochem. Biophys. Res. Commun. 2010, 402, 99–104. [Google Scholar] [CrossRef] [PubMed]
- Kusunoki, C.; Yang, L.; Yoshizaki, T.; Nakagawa, F.; Ishikado, A.; Kondo, M.; Morino, K.; Sekine, O.; Ugi, S.; Nishio, Y.; et al. Omega-3 polyunsaturated fatty acid has an anti-oxidant effect via the Nrf-2/HO-1 pathway in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2013, 430, 225–230. [Google Scholar] [CrossRef] [PubMed]
- Lee, S.E.; Kim, G.D.; Yang, H.; Son, G.W.; Park, H.R.; Cho, J.J.; Ahn, H.J.; Park, C.S.; Park, Y.S. Effects of Eicosapentaenoic Acid on the Cytoprotection Through Nrf2-Mediated Heme Oxygenase-1 in Human Endothelial Cells. J. Cardiovasc. Pharmacol. 2015, 66, 108–117. [Google Scholar] [CrossRef]
- Wen, C.; Jiang, M.; Huang, W.; Liu, S. Antarctic Krill Oil Attenuates Oxidative Stress via the KEAP1-NRF2 Signaling in Patients with Coronary Heart Disease. Evid. Based Complement. Alternat. Med. 2020, 2020, 9534137. [Google Scholar] [CrossRef]
- Bang, H.Y.; Park, S.A.; Saeidi, S.; Na, H.K.; Surh, Y.J. Docosahexaenoic Acid Induces Expression of Heme Oxygenase-1 and NAD(P)H:quinone Oxidoreductase through Activation of Nrf2 in Human Mammary Epithelial Cells. Molecules 2017, 22, 969. [Google Scholar] [CrossRef] [Green Version]
- Johansson, I.; Monsen, V.T.; Pettersen, K.; Mildenberger, J.; Misund, K.; Kaarniranta, K.; Schønberg, S.; Bjørkøy, G. The marine n-3 PUFA DHA evokes cytoprotection against oxidative stress and protein misfolding by inducing autophagy and NFE2L2 in human retinal pigment epithelial cells. Autophagy 2015, 11, 1636–1651. [Google Scholar] [CrossRef]
- Zhang, M.; Wang, S.; Mao, L.; Leak, R.K.; Shi, Y.; Zhang, W.; Hu, X.; Sun, B.; Cao, G.; Gao, Y.; et al. Omega-3 fatty acids protect the brain against ischemic injury by activating Nrf2 and upregulating heme oxygenase 1. J. Neurosci. 2014, 34, 1903–1915. [Google Scholar] [CrossRef]
- Zhu, W.; Cui, G.; Li, T.; Chen, H.; Zhu, J.; Ding, Y.; Zhao, L. Docosahexaenoic Acid Protects Traumatic Brain Injury by Regulating NOX. Neurochem. Res. 2020, 45, 1839–1850. [Google Scholar] [CrossRef]
- Riahi, Y.; Cohen, G.; Shamni, O.; Sasson, S. Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E879–E886. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Van Kuijk, F.J.; Holte, L.L.; Dratz, E.A. 4-Hydroxyhexenal: A lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochim. Biophys. Acta 1990, 1043, 116–118. [Google Scholar] [CrossRef]
- Zarrouki, B.; Soares, A.F.; Guichardant, M.; Lagarde, M.; Géloën, A. The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett. 2007, 581, 2394–2400. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ji, Y.; Dai, Z.; Wu, G.; Wu, Z. 4-Hydroxy-2-nonenal induces apoptosis by activating ERK1/2 signaling and depleting intracellular glutathione in intestinal epithelial cells. Sci. Rep. 2016, 6, 32929. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.; Kato, M.; Akhand, A.A.; Hayakawa, A.; Suzuki, H.; Miyata, T.; Kurokawa, K.; Hotta, Y.; Ishikawa, N.; Nakashima, I. 4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death. J. Cell. Sci. 2000, 113, 635–641. [Google Scholar] [CrossRef]
- Dalleau, S.; Baradat, M.; Guéraud, F.; Huc, L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013, 20, 1615–1630. [Google Scholar] [CrossRef] [Green Version]
- Jaganjac, M.; Tirosh, O.; Cohen, G.; Sasson, S.; Zarkovic, N. Reactive aldehydes--second messengers of free radicals in diabetes mellitus. Free Radic. Res. 2013, 47 (Suppl S1), 39–48. [Google Scholar] [CrossRef] [Green Version]
- Sandberg, M.; Patil, J.; D’Angelo, B.; Weber, S.G.; Mallard, C. NRF2-regulation in brain health and disease: Implication of cerebral inflammation. Neuropharmacology 2014, 79, 298–306. [Google Scholar] [CrossRef] [Green Version]
- Ranea-Robles, P.; Launay, N.; Ruiz, M.; Calingasan, N.Y.; Dumont, M.; Naudí, A.; Portero-Otín, M.; Pamplona, R.; Ferrer, I.; Beal, M.F.; et al. Aberrant regulation of the GSK-3β/NRF2 axis unveils a novel therapy for adrenoleukodystrophy. EMBO Mol. Med. 2018, 10, e8604. [Google Scholar] [CrossRef]
- Hashimoto, K. Essential Role of Keap1-Nrf2 Signaling in Mood Disorders: Overview and Future Perspective. Front. Pharmacol. 2018, 9, 1182. [Google Scholar] [CrossRef]
- Placidi, G.P.; Oquendo, M.A.; Malone, K.M.; Huang, Y.Y.; Ellis, S.P.; Mann, J.J. Aggressivity, suicide attempts, and depression: Relationship to cerebrospinal fluid monoamine metabolite levels. Biol. Psychiatry 2001, 50, 783–791. [Google Scholar] [CrossRef]
- Wiebenga, J.X.; Eikelenboom, M.; Heering, H.D.; van Oppen, P.; Penninx, B.W. Suicide ideation versus suicide attempt: Examining overlapping and differential determinants in a large cohort of patients with depression and/or anxiety. Aust. N. Z. J. Psychiatry 2021, 55, 167–179. [Google Scholar] [CrossRef] [PubMed]
- Brundin, L.; Erhardt, S.; Bryleva, E.Y.; Achtyes, E.D.; Postolache, T.T. The role of inflammation in suicidal behaviour. Acta Psychiatr. Scand. 2015, 132, 192–203. [Google Scholar] [CrossRef] [PubMed]
- Nock, M.K.; Hwang, I.; Sampson, N.A.; Kessler, R.C. Mental disorders, comorbidity and suicidal behavior: Results from the National Comorbidity Survey Replication. Mol. Psychiatry 2010, 15, 868–876. [Google Scholar] [CrossRef]
- Erhardt, S.; Lim, C.K.; Linderholm, K.R.; Janelidze, S.; Lindqvist, D.; Samuelsson, M.; Lundberg, K.; Postolache, T.T.; Träskman-Bendz, L.; Guillemin, G.J.; et al. Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2013, 38, 743–752. [Google Scholar] [CrossRef]
- Bjork, J.M.; Dougherty, D.M.; Moeller, F.G.; Swann, A.C. Differential behavioral effects of plasma tryptophan depletion and loading in aggressive and nonaggressive men. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2000, 22, 357–369. [Google Scholar] [CrossRef]
- Xu, J.; Donepudi, A.C.; More, V.R.; Kulkarni, S.R.; Li, L.; Guo, L.; Yan, B.; Chatterjee, T.; Weintraub, N.; Slitt, A.L. Deficiency in Nrf2 transcription factor decreases adipose tissue mass and hepatic lipid accumulation in leptin-deficient mice. Obesity 2015, 23, 335–344. [Google Scholar] [CrossRef] [Green Version]
- Wu, S.; Ding, Y.; Wu, F.; Xie, G.; Hou, J.; Mao, P. Serum lipid levels and suicidality: A meta-analysis of 65 epidemiological studies. J. Psychiatry Neurosci. JPN 2016, 41, 56–69. [Google Scholar] [CrossRef] [Green Version]
- Daray, F.M.; Mann, J.J.; Sublette, M.E. How lipids may affect risk for suicidal behavior. J. Psychiatr. Res. 2018, 104, 16–23. [Google Scholar] [CrossRef] [Green Version]
- Kułak-Bejda, A.; Bejda, G.; Lech, M.; Waszkiewicz, N. Are Lipids Possible Markers of Suicide Behaviors? J. Clin. Med. 2021, 10, 333. [Google Scholar] [CrossRef]
- Sigfridsson, E.; Marangoni, M.; Hardingham, G.E.; Horsburgh, K.; Fowler, J.H. Deficiency of Nrf2 exacerbates white matter damage and microglia/macrophage levels in a mouse model of vascular cognitive impairment. J. Neuroinflamm. 2020, 17, 367. [Google Scholar] [CrossRef] [PubMed]
- Bi, J.; Chen, C.; Sun, P.; Tan, H.; Feng, F.; Shen, J. Neuroprotective effect of omega-3 fatty acids on spinal cord injury induced rats. Brain Behav. 2019, 9, e01339. [Google Scholar] [CrossRef] [PubMed]
- Zgórzyńska, E.; Dziedzic, B.; Gorzkiewicz, A.; Stulczewski, D.; Bielawska, K.; Su, K.P.; Walczewska, A. Omega-3 polyunsaturated fatty acids improve the antioxidative defense in rat astrocytes via an Nrf2-dependent mechanism. Pharmacol. Rep. 2017, 69, 935–942. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kalkman, H.O. Potential Suicide Prophylactic Activity by the Fish Oil Metabolite, 4-Hydroxyhexenal. Int. J. Mol. Sci. 2022, 23, 6953. https://doi.org/10.3390/ijms23136953
Kalkman HO. Potential Suicide Prophylactic Activity by the Fish Oil Metabolite, 4-Hydroxyhexenal. International Journal of Molecular Sciences. 2022; 23(13):6953. https://doi.org/10.3390/ijms23136953
Chicago/Turabian StyleKalkman, Hans O. 2022. "Potential Suicide Prophylactic Activity by the Fish Oil Metabolite, 4-Hydroxyhexenal" International Journal of Molecular Sciences 23, no. 13: 6953. https://doi.org/10.3390/ijms23136953